Active

QBIC Arkiv Fund

Switched

BE0846496333

Rechtspersoon Public limited company 1 establishment

Ottergemsesteenweg-Zuid 808, 9000 Gent

Active for

14 year, 3 months

Financials

Financial year 2025

Worth noting

  • A loss two years in a row.

Gross margin

€ -59,399

▲ 6% vs 2024

Profit

Caution

€ -571,497

▲ 77% vs 2024

Debts

Low

€ 1,475

▼ 82% vs 2024

QBIC Arkiv Fund from Gent, company number BE0846496333, closed financial year 2025 with a result of € -571,497 after tax. For that financial year QBIC Arkiv Fund recorded a gross margin of € -59,399 and equity of € 6.5 million. Compared with financial year 2024, the result moved from € -2.5 million to € -571,497. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 1, 2026.

What happened at QBIC Arkiv Fund?

What happened at QBIC Arkiv Fund in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • Qbic Venture Partners BV stepped down as director. NBB
  • Participatiemaatschappij Vlaanderen NV stepped down as director. NBB
  • ING België NV stepped down as director. NBB
  • Cornelis Jan stepped down as director. NBB
  • Isabelle Cardinael stepped down as director. NBB
  • Rik Van De Walle stepped down as director. NBB
  • BNP Paribas Fortis Private Equity Belgium NV stepped down as director. NBB
  • Jean-Pierre Timmermans stepped down as director. NBB

In short

From € 10 million profit in 2021 to € 571,497 loss in 2025.

Paid € 102,790 in corporate taxes since 2021.

Best year ever: 2021, with € 10 million profit.

A new publication or filing at QBIC Arkiv Fund? We notify you, reason included.

Follow QBIC Arkiv Fund

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

QBIC Arkiv Fund

It owns 9.9% of Hydronic System Optimisation, 9.3% of Inbiose, 6.6% of Sentiance, 5.2% of Morrow, 4.5% of Unifly and 2.9% of Confo Therapeutics itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Qbic Venture Partners BV

Managing director · represented by Zabeau Marc

Also active at: Morrow, OVIZIO IMAGING SYSTEMS, QBIC Feeder Fund +2 more

since 2024 · until 2026

since 2024 · until 2026

since 2024 · until 2026

Cornelis Jan

Director

since 2024 · until 2026

Isabelle Cardinael

Director

Also active at: GEMMA FRISIUS-FONDS KU LEUVEN, Zeopore Technologies, QBIC Feeder Fund +1 more

since 2024 · until 2026

since 2024 · until 2026

BNP Paribas Fortis Private Equity Belgium NV

Director · represented by Patricia Terryn

Also active at: HET ANKER, Anima Research, STUDIO 100 +4 more

since 2024 · until 2026

Jean-Pierre Timmermans

Director

Also active at: QBIC Feeder Fund, QBIC Brussels Fund

since 2024 · until 2026

Steven Coppens

Director

Also active at: QBIC Feeder Fund, QBIC Brussels Fund

since 2024 · until 2026

Herman Verwilst

Director

Also active at: QBIC Feeder Fund

since 2024 · until 2026

Establishments

Establishment units

Physical locations of this company

Registered office

Ottergemsesteenweg-Zuid 808 box 328

9000 Gent

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0846.496.333
VAT number
BE 0846.496.333
Registered office
Ottergemsesteenweg-Zuid 808 bus 328, 9000 Gent
Names & denominations
QBIC Arkiv Fund
Enterprise type
Rechtspersoon
Legal form
Public limited company
Legal situation
Normale toestand
Start date
23 May 2012
Peppol
Active · Active since 10 Dec 2025

Frequently asked questions

What is the enterprise number of QBIC Arkiv Fund?
The enterprise number of QBIC Arkiv Fund is BE0846496333.
What is the address of QBIC Arkiv Fund?
The registered office of QBIC Arkiv Fund is located at Ottergemsesteenweg-Zuid 808 box 328, 9000 Gent.
When was QBIC Arkiv Fund founded?
QBIC Arkiv Fund was founded on 23 May 2012.
Does QBIC Arkiv Fund have a website?
No website is currently known for QBIC Arkiv Fund.
How much profit did QBIC Arkiv Fund make in 2025?
QBIC Arkiv Fund recorded a loss after taxes of € 571,497 in financial year 2025.
What is the revenue of QBIC Arkiv Fund?
As a small company, QBIC Arkiv Fund is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -59,399.
How many employees does QBIC Arkiv Fund have?
According to the 2025 annual accounts, QBIC Arkiv Fund has 0 full-time equivalents (FTE).
Where can I find the annual accounts of QBIC Arkiv Fund?
QBIC Arkiv Fund files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of QBIC Arkiv Fund?
According to the 2025 annual accounts, the directors of QBIC Arkiv Fund are: Qbic Venture Partners BV, Participatiemaatschappij Vlaanderen NV, ING België NV, Cornelis Jan, Isabelle Cardinael, Rik Van De Walle, BNP Paribas Fortis Private Equity Belgium NV, Jean-Pierre Timmermans.
Who owns QBIC Arkiv Fund?
It owns 9.9% of Hydronic System Optimisation, 9.3% of Inbiose, 6.6% of Sentiance, 5.2% of Morrow, 4.5% of Unifly and 2.9% of Confo Therapeutics itself.